Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-14

FDA Approved: AJOVY — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Ajovy (fremanezumab) from Teva as an original biologics license application for the preventive treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ajovy (fremanezumab)

Snippet

ORIG AP for AJOVY (FREMANEZUMAB-VFRM)